Regulation of Jak2 tyrosine kinase by protein kinase C during macrophage differentiation of IL-3-dependent myeloid progenitor cells

被引:36
|
作者
Kovanen, PE
Junttila, I
Takaluoma, K
Saharinen, P
Valmu, L
Li, WQ
Silvennoinen, O
机构
[1] Tampere Univ, Inst Med Technol, Lab Mol Immunol, FIN-33101 Tampere, Finland
[2] Tampere Univ Hosp, Dept Clin Microbiol, Tampere, Finland
[3] Haartman Inst, Dept Virol, Helsinki, Finland
[4] Univ Helsinki, Dept Biosci, Helsinki, Finland
[5] NCI, Cellular & Mol Biol Lab, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood.V95.5.1626.005k21_1626_1632
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Differentiation of macrophages from myeloid progenitor cells depends on a discrete balance between cell growth, survival, and differentiation signals. Interleukin-8 (IL-3) supports the growth and survival of myeloid progenitor cells through the activation of Jak2 tyrosine kinase, and macrophage differentiation has been shown to be regulated by protein kinase C (PKC). During terminal differentiation of macrophages, the cells lose their mitogenic response to IL-3 and undergo growth arrest, but the underlying signaling mechanisms have remained elusive. Here we show that in IL-3-dependent 32D myeloid progenitor cells, the differentiation-inducing PKC isoforms PKC-(C) 2000 by The American Society of Hematology alpha and PKC-delta specifically caused rapid inhibition of IL-3-induced tyrosine phosphorylation. The target for this inhibition was Jak2, and the activation of PKC by 12-O-tetradecanoyl-phorbol-13-acetate treatment also abrogated Ii-a-induced tyrosine phosphorylation of Jak2 in Ba/F3 cells, The mechanism of this regulation was investigated in 32D and COS7 cells, and the inhibition of Jak2 required catalytic activity of PKC-delta and involved the phosphorylation of Jak2 on serine and threonine residues by the associated PKC-delta, Furthermore, PKC-delta inhibited the in vitro catalytic activity of Jak2, indicating that Jak2 was a direct target for PKC-delta In 32D cells, the inhibition of Jak2 either by PKC-delta, tyrosine kinase inhibitor AG490, or IL-3 deprivation caused a similar growth arrest. Reversal of PKC-delta-mediated inhibition by the overexpression of Jak2 promoted apoptosis in differentiating 32D cells. These results demonstrate a PKC-mediated negative regulatory mechanism of cytokine signaling and Jak2, and they suggest that it serves to integrate growth-promoting and differentiation signals during macrophage differentiation. (C) 2000 by The American Society of Hematology.
引用
收藏
页码:1626 / 1632
页数:7
相关论文
共 50 条
  • [41] BIPHASIC REGULATION OF MACROPHAGE ATTACHMENT BY ACTIVATORS OF CYCLIC ADENOSINE MONOPHOSPHATE-DEPENDENT KINASE AND PROTEIN KINASE-C
    ISSAAD, C
    VENTURA, MA
    THOMOPOULOS, P
    JOURNAL OF CELLULAR PHYSIOLOGY, 1989, 140 (02) : 317 - 322
  • [42] Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells
    Muranyi, Andrew L.
    Dedhar, Shoukat
    Hogge, Donna E.
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (04) : 450 - 460
  • [43] Jak2 tyrosine kinase mediates oxidative stress-induced apoptosis in vascular smooth muscle cells
    Sandberg, EM
    Sayeski, PP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (33) : 34547 - 34552
  • [44] Jak2 tyrosine kinase mediates oxidative stress-induced apoptosis in vascular smooth muscle cells
    Sandberg, EM
    Sayeski, PP
    JOURNAL OF HYPERTENSION, 2004, 22 : S7 - S7
  • [45] Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells
    Joos, S
    Küpper, M
    Ohl, S
    von Bonin, F
    Mechtersheimer, G
    Bentz, M
    Marynen, P
    Möller, P
    Pfreundschuh, M
    Trümper, L
    Lichter, P
    CANCER RESEARCH, 2000, 60 (03) : 549 - 552
  • [46] Atiprimod inhibits the growth of JAK2 tyrosine kinase over-expressing cells "in vitro" and "ex vivo".
    Nussenzveig, Roberto
    Manshouri, Taghi
    Kantarjian, Hagop
    Giles, Francis
    Cortes, Jorge
    Gaikwad, Amos
    Priebe, Waldemar
    Estrov, Zeev
    Verstovsek, Srdan
    BLOOD, 2006, 108 (11) : 318B - 318B
  • [47] Implication of JAK1, JAK2, and JAK3 in the Realization of Proliferation and Differentiation Potential of Mesenchymal Progenitor Cells In Vitro
    G. N. Zyuz’kov
    V. V. Zhdanov
    E. V. Udut
    L. A. Miroshnichenko
    E. V. Simanina
    T. Yu. Polyakova
    A. V. Chaikovskii
    L. A. Stavrova
    V. V. Udut
    V. I. Agafonov
    Ya. V. Burmina
    M. G. Danilets
    M. Yu. Minakova
    A. M. Dygai
    Bulletin of Experimental Biology and Medicine, 2016, 161 : 224 - 227
  • [48] Implication of JAK1, JAK2, and JAK3 in the Realization of Proliferation and Differentiation Potential of Mesenchymal Progenitor Cells In Vitro
    Zyuz'kov, G. N.
    Zhdanov, V. V.
    Udut, E. V.
    Miroshnichenko, L. A.
    Simanina, E. V.
    Polyakova, T. Yu.
    Chaikovskii, A. V.
    Stavrova, L. A.
    Udut, V. V.
    Agafonov, V. I.
    Burmina, Ya. V.
    Danilets, M. G.
    Minakova, M. Yu.
    Dygai, A. M.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 161 (02) : 224 - 227
  • [49] Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains
    Williams, Neal K.
    Bamert, Rebecca S.
    Patel, Onisha
    Wang, Christina
    Walden, Patricia M.
    Wilks, Andrew F.
    Fantino, Emmanuelle
    Rossjohn, Jamie
    Lucet, Isabelle S.
    JOURNAL OF MOLECULAR BIOLOGY, 2009, 387 (01) : 219 - 232
  • [50] REGULATION OF G1/S TRANSITION BY CYCLIN D2 AND D3 IN IL-3-DEPENDENT MYELOID CELLS
    ANDO, K
    GRIFFIN, JD
    BLOOD, 1993, 82 (10) : A182 - A182